← All indications
Wound Infection
Invasion of a wound by pathogenic microorganisms.
Subtype terms (1)
More specific conditions that are subtypes of Wound Infection in the MeSH hierarchy.
- Surgical Wound Infection
69 drugs (55 approved, 14 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (28)
- metronidazole
- procaine benzylpenicillin
- tobramycin
- cefazolin
- clavulanate
- flucloxacillin
- daptomycin
- iodine
- amoxicillin
- mupirocin
- piperacillin
- ceftriaxone
- sulbactam
- teicoplanin
- vancomycin
- sulfadoxine
- gentamicin
- cefoperazone
- tranexamic acid
- cefuroxime
- clindamycin
- pyrimethamine
- phenoxymethylpenicillin
- benzalkonium
- chlorhexidine
- tazobactam
- erythromycin
- ampicillin
Phase 3 trials (11)
Phase 2 trials (10)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (51)
- Novartis
- Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- Cubist
- GlaxoSmithKline
- Mepha Ltd.
- Next Science
- Semmes-Murphey Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- Harvard University
- Georgetown University
- Gottfried Wilhelm Leibniz Universität Hannover
- Hospital de Granollers
- Mahidol University
- Mater Misericordiae University Hospital
- Minia University
- National Cheng Kung University
- Universitat Internacional de Catalunya
- University of Hull
- University of Lausanne
- University of Milan
- University of Southern Denmark
- University of Tennessee
- University of Bern
- West Virginia University
- Royal College of Surgeons, Ireland
- Tel Aviv University
- University of California, San Francisco
- University of Copenhagen
- Icahn School of Medicine at Mount Sinai
- Tribhuvan University
- +21 more
Organization Involved with Phase 3 Indications (20)
- Durata
- The Medicines Company
- Allergan
- Bayer
- Innocoll
- Baylor University
- University of London
- Duke University
- Hillel Yaffe Medical Center
- Medical College of Wisconsin
- University of Louisville
- University of Rochester
- University of Birmingham
- Assiut University
- Royal Marsden Hospital NHS Trust
- Premier Research Group
- Royal Hobart Hospital, TAS, Australia
- Humboldt University
- Department of Veteran Affairs
- National Institute for Health Research, United Kingdom
Organization Involved with Phase 2 Indications (15)
- Theravance
- Pherecydes Pharma
- PolyPid Ltd.
- Affinium Pharmaceuticals, Ltd
- Pulmatrix Inc.
- University of Arizona
- University of South Alabama
- University of Alberta
- University of Virginia
- Zagazig University
- University of California, San Diego
- Shoals Medical Trials
- BJJS Corporation
- St. Barnabas Medical Center, Livingston, NJ
- Government of Egypt
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (32)
- Sonescence, Inc.
- Aultman Health Foundation
- National Institutes of Health (NIH)
- The Methodist Hospital System
- Quanhong Zhou
- Alexandria University
- HealthPartners Institute
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Ochsner Health System
- Oregon Health and Science University
- Seoul National University
- Sutter Health
- Universidade do Vale do Sapucai
- University of Oslo
- University of South Carolina
- Columbia University
- University of Utah
- Medical University of South Carolina
- Jiao Tong University
- Orebro University
- University of Texas at Houston
- University of North Carolina at Chapel Hill
- Free University of Brussels
- Sonoma West Medical Center
- Methodist Cancer Center, Houston, Texas
- University of Mississippi
- Mission Health, North Carolina
- University of Alabama, Birmingham
- Linkoping University
- Lady Hardinge Medical College
- +2 more